SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Jun 4, 2018

2. SEC Identification Number

ASO93-7946

3. BIR Tax Identification No.

003-831-302-000

4. Exact name of issuer as specified in its charter

Alliance Global Group, Inc.

5. Province, country or other jurisdiction of incorporation

Metro Manila

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

7th Floor, 1880 Eastwood Avenue, Eastwood City CyberPark, E. Rodriguez, Jr. Avenue, Bagumbayan, Quezon City, Metro Manila, Philippines Postal Code 1110

8. Issuer's telephone number, including area code

(632) 709-2038 to 41

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common	10,129,529,779
Treasury	140,298,200

11. Indicate the item numbers reported herein

Item 9(b)

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Alliance Global Group, Inc.AGI

PSE Disclosure Form 4-8 - Change in Directors and/or Officers
(Resignation/Removal or Appointment/Election)
References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Change in Officers
Background/Description of the Disclosure
The Board of Directors of Alliance Global Group, Inc. (the “Company”) has accepted today, 04 June 2018, the resignation of Dr. Andrew L. Tan as Chief Executive Officer (“CEO”). Dr. Tan will remain as Chairman of the Board of Directors of the Company. Dr. Tan has no disagreement with the Corporation on any matter relating to its operations, policies or practices. In view of the resignation of Dr. Tan as CEO, the members of the Board of Directors appointed Mr. Kevin Andrew L. Tan as the new CEO of the Company.

Resignation/Removal or Replacement

Name of Person	Position/Designation	Effective Date of Resignation/Cessation of term (mmm/dd/yyyy)	Reason(s) for Resignation/Cessation
Andrew L. Tan	Chief Executive Officer	June 04,2018	Personal

Election or Appointment

Name of Person	Position/Designation	Date of Appointment/Election (mmm/dd/yyyy)	Effective Date of Appointment Election (mmm/dd/yyyy)	Shareholdings in the Listed Company		Nature of Indirect Ownership
				Direct	Indirect
Kevin Andrew L. Tan	Chief Executive Officer	June 04,2018	June 04,2018	1	0	-

Promotion or Change in Designation

Name of Person	Position/Designation		Date of Approval (mmm/dd/yyyy)	Effective Date of Change (mmm/dd/yyyy)	Shareholdings in the Listed Company		Nature of Indirect Ownership
	From	To			Direct	Indirect
N.A.	N.A.	N.A.	N.A.	N.A.	-	-	N.A.

Other Relevant Information
Please see attached copy of SEC Form 17-C.